Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients

Clinical trial NCT05474560 · COMPLETED

Trial details

NCT number: NCT05474560
Sponsor: Ain Shams University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non-Alcoholic Fatty Liver Disease Hyperuricemia

Start date: 2022-01-01
Primary completion: 2023-01-28
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.